Business Context and Reporting Period
This Form 8-K filing by Acadia Healthcare Company, Inc. reports on events occurring on April 7, 2014, with the report filed on April 11, 2014. The filing focuses on Item 5.02 regarding the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly limited to executive compensation terms and does not contain financial performance data.
Material Changes
The primary material change is the approval by the compensation committee of amended and restated employment agreements for four existing executives and an initial agreement for the Chief Financial Officer, effective April 7, 2014. The executives involved are:
- Joey A. Jacobs (Chairman and CEO)
- Brent Turner (President)
- Ronald M. Fincher (COO)
- Christopher L. Howard (EVP, General Counsel, and Secretary)
- David M. Duckworth (CFO)
Guidance, Outlook, and Management Commentary
The filing details specific modifications to executive compensation structures, including:
- Target Annual Cash Bonuses: Set at 110% of base salary for Mr. Jacobs; 85% for Messrs. Turner, Fincher, and Howard; and 75% for Mr. Duckworth.
- Maximum Cash Bonuses: Established at two times the target annual cash bonus for all executives.
- 2014 Long-Term Incentive Awards: Minimum amounts set at 340% of base salary for Mr. Jacobs; 175% for Messrs. Turner, Fincher, and Howard; and 125% for Mr. Duckworth.
- Termination Benefits: Enhanced severance packages for termination without cause or resignation for good reason, including multipliers on base salary and bonuses, and extended benefit continuation periods (ranging from 12 to 36 months).
- Equity Vesting: Immediate vesting of equity awards upon specific termination events.
- Non-Competition: Established non-competition and non-solicitation periods of 36 months for Mr. Jacobs, 24 months for Messrs. Turner, Fincher, and Howard, and 12 months for Mr. Duckworth.
Investor Verification Checklist
- Review the full text of Exhibits 10.1 through 10.5 to verify specific performance metrics tied to the bonus and long-term incentive awards.
- Confirm the total potential cash and equity payout obligations under the new termination provisions.
- Assess the impact of the increased compensation targets on the company's future operating expenses.
- Verify the specific definitions of "good reason" and "without cause" within the attached employment agreements.